Arpelos Biosciences
Delivering enduring outcomes for patients
Cambridge, United States · Founded 2021 · $9.5M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- arpelos.com
- Total Funding
- $9.5M
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round for this company. The full record is or through the API.
About
Arpelos Biosciences develops drugs through an AI-native approach focused on immunology, with an emphasis on enduring patient outcomes.
Summary
Arpelos Biosciences is a Biotech company based in Cambridge, United States, founded in 2021. It has raised $9.5M in total across 1 round.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/arpelos-biosciences"><img src="https://indexed.vc/api/badge/company/arpelos-biosciences" alt="Arpelos Biosciences on Indexed.vc" width="260" height="76" /></a>